Moody Lynn & Lieberson’s Boston Scientific BSX Stock Holding History

Moody Lynn & Lieberson’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,170	Closed	-$577K	–	208
2019 Q3	$577K	Hold	14,170	–	–	0.06%	124
2019 Q2	$609K	Sell	14,170 -4,560	-24%	-$175K	0.07%	133
2019 Q1	$719K	Sell	18,730 -147,700	-89%	-$5.64M	0.08%	112
2018 Q4	$5.88M	Sell	166,430 -8,850	-5%	-$321K	0.79%	41
2018 Q3	$6.75M	Buy	175,280 +750	+0.4%	+$26.2K	0.72%	44
2018 Q2	$5.71M	Buy	+174,530	New	+$5.26M	0.67%	46
2017 Q4	–	Sell	-75,340	Closed	-$2.2M	–	210
2017 Q3	$2.2M	Sell	75,340 -58,671	-44%	-$1.62M	0.27%	76
2017 Q2	$3.71M	Buy	+134,011	New	+$3.56M	0.49%	56
2016 Q4	–	Sell	-302,310	Closed	-$7.2M	–	171
2016 Q3	$7.2M	Sell	302,310 -480	-0.2%	-$11.5K	1.2%	34
2016 Q2	$7.08M	Buy	302,790 +108,000	+55%	+$2.34M	1.27%	30
2016 Q1	$3.66M	Buy	+194,790	New	+$3.42M	0.58%	59

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Moody Lynn & Lieberson's BSX Position: Q4 2019 in Review

Moody Lynn & Lieberson sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 14,170 shares — an estimated $577K sold.

Moody Lynn & Lieberson first reported a position in BSX in Q1 2016 and held it in 11 quarters. The position peaked at $7.2M in Q3 2016. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Moody Lynn & Lieberson reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Moody Lynn & Lieberson sold 14,170 Boston Scientific shares in Q4 2019, an estimated $577K.
Moody Lynn & Lieberson first reported a position in Boston Scientific in Q1 2016 and held it in 11 quarters.
Moody Lynn & Lieberson's Boston Scientific position peaked at $7.2M in Q3 2016.
854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2019, filed 28 Jan 2020.